Evidence map›Paper›PMID 35710644›Full record

ArticleNature communications2022

T-cell trans-synaptic vesicles are distinct and carry greater effector content than constitutive extracellular vesicles.

Pablo F Céspedes, Ashwin Jainarayanan, Lola Fernández-Messina, Salvatore Valvo, David G Saliba, Elke Kurz, Audun Kvalvaag, Lina Chen, Charity Ganskow, Huw Colin-York and 16 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. The physical landscape of CAR-T synapse.Biophysical journal · 2024
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 5 institutions in 3 countries.

Pablo F Céspedes *Kennedy Institute of Rheumatology, Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, The University of Oxford, Oxford, UK. pablo.cespedes@kennedy.ox.ac.uk.ORCID 0000-0002-1641-4107
Ashwin Jainarayanan *Kennedy Institute of Rheumatology, Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, The University of Oxford, Oxford, UK.
Lola Fernández-MessinaImmunology Service, Hospital de la Princesa, Instituto Investigación Sanitaria Princesa, Universidad Autónoma de Madrid, Madrid, Spain.ORCID 0000-0002-2163-8746
Salvatore ValvoKennedy Institute of Rheumatology, Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, The University of Oxford, Oxford, UK.
David G SalibaKennedy Institute of Rheumatology, Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, The University of Oxford, Oxford, UK.ORCID 0000-0001-9523-0586
Elke KurzKennedy Institute of Rheumatology, Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, The University of Oxford, Oxford, UK.
Audun KvalvaagKennedy Institute of Rheumatology, Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, The University of Oxford, Oxford, UK.
Lina ChenKennedy Institute of Rheumatology, Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, The University of Oxford, Oxford, UK.ORCID 0000-0001-6713-2372
Charity GanskowKennedy Institute of Rheumatology, Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, The University of Oxford, Oxford, UK.ORCID 0000-0001-9779-4844
Huw Colin-YorkKennedy Institute of Rheumatology, Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, The University of Oxford, Oxford, UK.ORCID 0000-0002-6585-3237
Marco FritzscheKennedy Institute of Rheumatology, Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, The University of Oxford, Oxford, UK.ORCID 0000-0002-8712-7471
Yanchun PengMRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, The University of Oxford, Oxford, UK.ORCID 0000-0003-2340-0499
Tao DongMRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, The University of Oxford, Oxford, UK.
Errin JohnsonSir William Dunn School of Pathology, The University of Oxford, Oxford, UK.
Jesús A Siller-FarfánSir William Dunn School of Pathology, The University of Oxford, Oxford, UK.ORCID 0000-0001-6624-7637
Omer DushekSir William Dunn School of Pathology, The University of Oxford, Oxford, UK.ORCID 0000-0001-5847-5226
Erdinc SezginScience for Life Laboratory, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-4915-388X
Ben PeacockNanoFCM, MediCity, Nottingham, UK.ORCID 0000-0002-7823-8719
Alice LawNanoFCM, MediCity, Nottingham, UK.
Dimitri AubertNanoFCM, MediCity, Nottingham, UK.
Simon EngledowOxford Genomics Centre, Wellcome Centre for Human Genetics, The University of Oxford, Oxford, UK.ORCID 0000-0002-0510-8526
Moustafa AttarKennedy Institute of Rheumatology, Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, The University of Oxford, Oxford, UK.ORCID 0000-0003-4116-1276
Svenja HesterTarget Discovery Institute, Centre for Medicines Discovery, Nuffield Department of Medicine, The University of Oxford, Oxford, UK.
Roman FischerTarget Discovery Institute, Centre for Medicines Discovery, Nuffield Department of Medicine, The University of Oxford, Oxford, UK.ORCID 0000-0002-9715-5951
Francisco Sánchez-MadridImmunology Service, Hospital de la Princesa, Instituto Investigación Sanitaria Princesa, Universidad Autónoma de Madrid, Madrid, Spain.
Michael L DustinKennedy Institute of Rheumatology, Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, The University of Oxford, Oxford, UK. michael.dustin@kennedy.ox.ac.uk.ORCID 0000-0003-4983-6389
University of Oxford · GBCentre for Human Genetics · GBNuffield Orthopaedic Centre · GBSpanish National Centre for Cardiovascular Research · ESScience for Life Laboratory · SE

Funding

Biotechnology and Biological Sciences Research CouncilMedical Research Council MR/L018942/1Wellcome TrustWellcome Trust 091911Wellcome Trust 100262Z/12/ZWellcome Trust 107457Wellcome Trust 203141/Z/16/ZWellcome Trust 212343/Z/18/Z
6 · The paper itself

Abstract

The immunological synapse is a molecular hub that facilitates the delivery of three activation signals, namely antigen, costimulation/corepression and cytokines, from antigen-presenting cells (APC) to T cells. T cells release a fourth class of signaling entities, trans-synaptic vesicles (tSV), to mediate bidirectional communication. Here we present bead-supported lipid bilayers (BSLB) as versatile synthetic APCs to capture, characterize and advance the understanding of tSV biogenesis. Specifically, the integration of juxtacrine signals, such as CD40 and antigen, results in the adaptive tailoring and release of tSV, which differ in size, yields and immune receptor cargo compared with steadily released extracellular vesicles (EVs). Focusing on CD40L

Indexed as

CD40 LigandExtracellular VesiclesImmunological SynapsesSynaptic VesiclesT-LymphocytesCD40 Ligand

Identifiers

PMID35710644
PMCPMC9203538
OpenAlexW4282978061

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.